![](/img/cover-not-exists.png)
PCN70 Cost Effectiveness Analysis Based on Progression Free Survival (PFS) of Pazopanib Versus Sunitinib for the Treatment of Advanced Renal Cell Carcinoma (ARCC) in the Mexican Context
Anaya, P., Delea, T.E., Pichardo, P., Diaz, J.R.Volume:
15
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2012.03.1187
Date:
June, 2012
File:
PDF, 61 KB
english, 2012